- US12528782utility2026Prodrugs in the Modulation of Interleukin0 cites
- US12528827utility2026Tricyclic Heteroaryl-substituted Quinoline and Azaquinoline Compounds as PAR4 Inhibitors0 cites
- US12492172utility2025Substituted Quinazolinyl Compounds Useful as T Cell Activators0 cites
- US12492186utility2025Bicyclic Heterocyclic Compounds Useful as IRAK4 Inhibitors0 cites
- US12492188utility20251h-benzo[d]imidazole Derivatives as TLR9 Inhibitors for the Treatment of Fibrosis0 cites
- US12492202utility2025Macrocyclic PAD4 Inhibitors Useful as Immunosuppressant0 cites
- US12492238utility2025Glypican-3-binding Fibronectin Based Scaffold Molecules0 cites
- US12485123utility20251 H -pyrazolo[4,3- D ]pyrimidine Compounds as Toll-like Receptor 7 (TLR7) Agonists0 cites
- US12486525utility2025Methods for Increasing Productivity of Therapeutic Proteins0 cites
- US12478674utility2025Ipilimumab Variants with Enhanced Specificity for Binding at Low Ph0 cites
- US12478686utility2025Antibodies Modified for Transglutaminase Conjugation, Conjugates Thereof, and Methods and Uses0 cites
- US12473290utility2025Imidazopyridazine Compounds Useful as Modulators of IL-12, IL-23 And/or IFN Alpha Responses0 cites
- US12473304utility2025Heterocyclic PAD4 Inhibitors0 cites
- US12474298utility2025Isoelectric Focusing Sample Matrix0 cites
- US12466804utility2025Cyclobutyl Carboxylic Acids as LPA Antagonists0 cites
- US12466875utility2025Supramolecular High Affinity Protein-binding System for Purification of Biomacromolecules0 cites